Experimental atherosclerosis in rabbits: Platelet aggregation, thromboxane A2 generation and anti-aggregatory potency of prostacyclin
- 1 December 1977
- journal article
- research article
- Published by Elsevier in Prostaglandins
- Vol. 14 (6), 1035-1042
- https://doi.org/10.1016/0090-6980(77)90283-0
Abstract
No abstract availableThis publication has 25 references indexed in Scilit:
- The generation of prostacyclin by arteries and by the coronary vascular bed is reduced in experimental atherosclerosis in rabbitsProstaglandins, 1977
- : A selective inhibitor of thromboxane synthetaseProstaglandins, 1977
- A potent inhibitor of thromboxane A2 biosynthesis in aggregating human blood plateletsPharmacological Research Communications, 1977
- Arterial walls are protected against deposition of platelet thrombi by a substance (prostaglandin X) which they make from prostaglandin endoperoxidesProstaglandins, 1976
- An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregationNature, 1976
- Identification of an enzyme in platelet microsomes which generates thromboxane A2 from prostaglandin endoperoxidesNature, 1976
- Inhibition by sulfhydryl agents of arachidonic acid-induced platelet aggregation and release of potential inflammatory substancesProstaglandins, 1974
- Platelet Aggregation induced by Arachidonic Acid is accompanied by Release of Potential Inflammatory Mediators distinct from PGE2 and PGF2Nature New Biology, 1973
- Cholesterol esterifying enzymes of atherosclerotic rabbit intimaBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1972
- Aggregation of Blood Platelets by Adenosine Diphosphate and its ReversalNature, 1962